...
首页> 外文期刊>International Journal of Polymer Science >Development of Bioadhesive Microspheres for Oral Bioavailability Enhancement of Berberine Hydrochloride
【24h】

Development of Bioadhesive Microspheres for Oral Bioavailability Enhancement of Berberine Hydrochloride

机译:增强盐酸小ber碱口服生物利用度的生物粘附性微球的开发

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to innovatively prepare chitosan-coated alginate/gelatin BBH loaded microspheres and evaluate their pharmaceutical characteristics and pharmacokinetics. The bioadhesive microspheres were prepared using an emulsification technique. Three batches of microspheres were formed and their stability was evaluated. BBH loaded microspheres were almost spherical with shallow elevation on surfaces. The mean particle size of microspheres was 368,2 μm, drug loading was 3.59 + 0.01%, and in situ bioadhesion percentage was 91.23% ± 8.2% and they achieved a sustained release with 71.29% for 8 hours in vitro. Pharmacokinetic studies in rats indicated that the bioavailability of BBH microspheres was enhanced about 1.5-fold as compared with commercial tablets. BBH microspheres exhibited a sustained-release profile over 48 h. Thus, chitosan-coated alginate/gelatin BBH loaded microspheres which combined the advantages of alginate/gelatin microspheres and chitosan may be used as a sustained delivery system for BBH to treat duodenal and benign gastric ulcers.
机译:这项研究的目的是创新地制备壳聚糖涂层的藻酸盐/明胶BBH负载微球,并评估其药物特性和药代动力学。使用乳化技术制备生物粘附性微球。形成三批微球并评估其稳定性。负载BBH的微球几乎是球形的,表面高度较浅。微球的平均粒径为368,2μm,载药量为3.59 + 0.01%,原位生物粘附百分比为91.23%±8.2%,在体外8小时内达到了71.29%的持续释放。大鼠体内的药代动力学研究表明,与市售片剂相比,BBH微球的生物利用度提高了约1.5倍。 BBH微球在48小时内表现出持续释放特性。因此,结合了藻酸盐/明胶微球和壳聚糖的优点的壳聚糖包被的藻酸盐/明胶BBH微球可以用作BBH的持续递送系统,以治疗十二指肠和良性胃溃疡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号